Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EBIT (2016 - 2025)

Prestige Consumer Healthcare has reported EBIT over the past 16 years, most recently at $82.5 million for Q4 2025.

  • Quarterly results put EBIT at $82.5 million for Q4 2025, down 10.3% from a year ago — trailing twelve months through Dec 2025 was $322.3 million (down 2.47% YoY), and the annual figure for FY2025 was $336.8 million, down 1.65%.
  • EBIT for Q4 2025 was $82.5 million at Prestige Consumer Healthcare, up from $79.7 million in the prior quarter.
  • Over the last five years, EBIT for PBH hit a ceiling of $92.0 million in Q4 2024 and a floor of -$281.0 million in Q1 2023.
  • Median EBIT over the past 5 years was $83.5 million (2021), compared with a mean of $64.6 million.
  • Biggest five-year swings in EBIT: tumbled 462.93% in 2023 and later surged 129.24% in 2024.
  • Prestige Consumer Healthcare's EBIT stood at $82.6 million in 2021, then rose by 5.56% to $87.2 million in 2022, then fell by 0.4% to $86.8 million in 2023, then rose by 5.91% to $92.0 million in 2024, then fell by 10.3% to $82.5 million in 2025.
  • The last three reported values for EBIT were $82.5 million (Q4 2025), $79.7 million (Q3 2025), and $71.8 million (Q2 2025) per Business Quant data.